GPCR Earnings & Financial Statements
Structure Therapeutics Inc.
$22.19
+$0.31(+1.42%)
29
Overall
--
Value
36
Tech
23
Quality
Market Cap
$1.56B
Volume
1.15M
52W Range
$25.09 - $94.90
Target Price
$106.73
GPCR earnings and financial statements: Structure Therapeutics Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
GPCR Annual Financial Statements
| Fiscal year | 2024 | 2023 |
|---|---|---|
| Operating income | -$158.23M | -$102.78M |
| EBITDA | -$121.22M | -$89.08M |
| Net income | -$122.53M | -$89.62M |
| EPS (diluted) | $-0.78 | $-2.44 |
| Fiscal year | 2024 | 2023 |
|---|---|---|
| Total assets | $903.33M | $482.02M |
| Total liabilities | $38.49M | $29.05M |
| Shareholders’ equity | $864.84M | $452.97M |
| Cash and equivalents | $169.51M | $129.79M |
| Long-term debt | $2.16M | $4.01M |
| Fiscal year | 2024 | 2023 |
|---|---|---|
| Operating cash flow | -$116.64M | -$79.49M |
| Capital expenditure | -$1.29M | -$2.17M |
| Free cash flow | -$117.93M | -$81.66M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GPCR | $22.19 | +1.4% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Structure Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW